Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine spray for radiotherapy-induced oral mucositis
NCT07082621Completed
- Start
- Jan 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetylcysteine in oral mucositis (OM) (2 arms). Primary endpoints: Change in pain scores at 6 weeks and change in oral mucositis severity at 6 weeks. Started Jan 2024; status: completed.
02
Drugs
acetylcysteine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07082621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07082621.